BioSpace News Archive

Clinical trials are a traditional ways to determine the safety and efficiency of a drug or a medical device, or any other therapeutic product.

The HEART Act, sponsored by Congressman Paul Tonko (D-NY) and David B. McKinley (R-WV) and supported by HAYSTACK Project and other leading advocacy groups, calls for more involvement from rare disease patients and experts in regulatory reviews. [09-July-2020] ALBANY, N.Y. , July 9, 2020 /PRNewswire/ -- The FCS Foundation, the nation’s leading advocacy and support orga

The very basic of research, exploration, and science is taught to student during their school or college days. One of the basic thing that is being taught is use of the microscopes to the students pertaining to biology and chemistry domains. To teach and train students in the field of science, countries like India, China and U.S. are building new institutions.

Medline announced a new partnership with Falck USA, the country’s second largest privately owned ambulance service provider, designed to make a portfolio of high quality products available to members to drive operational and cost efficiencies.

Deborah Heart and Lung Center -- New Jersey’s only specialty heart, lung, and vascular center, and an Alliance Partner of the Cleveland Clinic Heart, Vascular & Thoracic Institute -- has announced a new partnership with Sidney Kimmel Medical College at Thomas Jefferson University for Deborah’s Fellowship Programs.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today the appointment of Georgia Garinois-Melenikiotou to the Board of Directors.

Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 15/959,482. T

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter financial results on Wednesday August 5, 2020 at 7:00 a.m. ET.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary second quarter financial results.

Arcus Biosciences, Inc., an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 190,200 shares of the Company’s common stock at an exercise price per share of $25.28, which was the closing price on July 8, 2020.